VeraFlo With Prontosan® and Wound and Fracture Healing.

Stopped early · Not applicable

Conditions studied: Infection

In brief

To answer the question: "Do Prontosan instillations decrease time to wound and fracture healing and decrease bacterial load compared to wound vac treatment without Prontosan?," we will enroll up to 30 subjects (for an anticipated 20 complete data sets) into this trial. The subjects will be split equally into two different groups by randomization. One groups will have wound vac therapy with Prontosan, and one group will have wound vac therapy without Prontosan. Data related to wound and fracture healing and bacterial load will be assessed between the two groups to determine if wound vac therapy with Prontosan speeds up healing time and decreases bacterial load.

Key facts

Study ID

NCT02621073

Run by

Brett Crist

People needed

7

Starts

2015-11-01

Expected to finish

2017-12-01

Last updated by the study team

2019-06-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years and older
• Patients who will be undergoing surgical management (including the use of NPWT therapy) of an infected lower extremity status-post open reduction and internal fixation (ORIF)

You may not qualify if…

• Pregnant females
• Incarcerated patients and those not able to give informed consent

Where it is running

• University of Missouri — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.